The Cantwell-Grassley PBM transparency bill directs the FTC to end well-known and documented PBM practices that drive up consumer price.
Improved information sharing between CBP and its private-sector partners would aid efforts to identify and curtail the s...
The Cantwell-Grassley PBM Transparency Act directs the FTC to end well-known and documented PBM practices that drive up ...
FMI thanks Chairwoman Cantwell and Sen. Grassley for championing the PBM Transparency Act.
I'll flag one other concern for the bill. It would pre-judge the results of the FTC's current study on the economic effe...
I've hauled Big Pharma and PBM executives before the Finance Committee.
PBMs are blocking a cheaper product.
Today, three PBMs control 80 percent of the market. We must do something about powerful middlemen to lower drug costs fo...
I worked at the FTC, and I can tell you that with the Agency's overreach and activism, which will no doubt be difficult ...
Our investigation found that the PBM scheme encourages drug makers to spike the drug's list price.
So, let's just assume that the FDIC or some other regulator or bank say to the community bank in Parkersburg, Iowa that ...